CRESCENDO BIOLOGICS - Trademark Details
Status: 700 - Registered
Serial Number
79209645
Registration Number
5488713
Word Mark
CRESCENDO BIOLOGICS
Status
700 - Registered
Status Date
2018-06-12
Filing Date
2016-10-21
Registration Number
5488713
Registration Date
2018-06-12
Mark Drawing
3000 - Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s)
Typeset
Design Searches
261709 - Curved line(s), band(s) or bar(s).
Published for Opposition Date
2018-03-27
Attorney Name
Law Office Assigned Location Code
L50
Employee Name
LEE, JEANIE H
Statements
Indication of Colors claimed
Color is not claimed as a feature of the mark.
Disclaimer with Predetermined Text
"BIOLOGICS"
Description of Mark
The mark consists of a design of three circles each having U-shaped cut-outs. The three circles are centered above the stylized wording "Crescendo" directly above the stylised wording "biologics".
Goods and Services
Chemicals used in industry and science; chemicals for laboratory research purposes, namely, chemical tests kits for in vitro testing; antibodies and antibody fragments for scientific and laboratory use in the nature of biochemical, namely, monoclonal antibodies for in vitro scientific or research use; biochemical, namely, monoclonal antibodies and antibody fragments for scientific and laboratory use; antibodies and antibody fragments all being protein in raw material form for scientific research purposes; antibody reagents used for the detection of antigens in cell and tissue analysis for scientific and laboratory in vitro diagnostic use; antibodies and antibody fragments all being proteins for industrial use in the discovery, preclinical and clinical development of therapeutic products
Goods and Services
Pharmaceutical preparations for the treatment of cancer, autoimmune diseases, inflammatory conditions, allergies and allergic conditions, hypersensitivity reactions, infections, organ transplant rejection, tissue transplant rejection, cardiovascular diseases, neurological disorders, degenerative disorders, metabolic disorders, dermatological diseases; veterinary preparations for the treatment of cancer, autoimmune diseases, inflammatory conditions, allergies and allergic conditions, hypersensitivity reactions, infections, organ transplant rejection, tissue transplant rejection, cardiovascular diseases, neurological disorders, degenerative disorders, metabolic disorders, dermatological diseases; therapeutic preparations in the nature of antibodies and antibody fragments for medical and veterinary purposes, namely, therapeutic pharmaceutical preparations for the treatment of cancer, autoimmune diseases, inflammatory conditions, allergies and allergic conditions, hypersensitivity reactions, infections, organ transplant rejection, tissue transplant rejection, cardiovascular diseases, neurological disorders, degenerative disorders, metabolic disorders, dermatological diseases; antibodies, being pharmaceutical preparations for the treatment of cancer, autoimmune diseases, inflammatory conditions, allergies and allergic conditions, hypersensitivity reactions, infections, organ transplant rejection, tissue transplant rejection, cardiovascular diseases, neurological disorders, degenerative disorders, metabolic disorders, dermatological diseases; antibody fragments, being pharmaceutical preparations for the treatment of cancer, autoimmune diseases, inflammatory conditions, allergies and allergic conditions, hypersensitivity reactions, infections, organ transplant rejection, tissue transplant rejection, cardiovascular diseases, neurological disorders, degenerative disorders, metabolic disorders, dermatological diseases; monoclonal antibody therapies for therapeutic purposes, being pharmaceutical preparations for the treatment of cancer, autoimmune diseases, inflammatory conditions, allergies and allergic conditions, hypersensitivity reactions, infections, organ transplant rejection, tissue transplant rejection, cardiovascular diseases, neurological disorders, degenerative disorders, metabolic disorders, dermatological diseases; antibodies and antibody fragments, being pharmaceutical preparations for the treatment of cancer, autoimmune diseases, inflammatory conditions, allergies and allergic conditions, hypersensitivity reactions, infections, organ transplant rejection, tissue transplant rejection, cardiovascular diseases, neurological disorders, degenerative disorders, metabolic disorders, dermatological diseases, for medical and veterinary diagnostics; antibodies and antibody fragments, being pharmaceutical preparations for the treatment of cancer, autoimmune diseases, inflammatory conditions, allergies and allergic conditions, hypersensitivity reactions, infections, organ transplant rejection, tissue transplant rejection, cardiovascular diseases, neurological disorders, degenerative disorders, metabolic disorders, dermatological diseases, for use in the discovery, preclinical and clinical development of therapeutic products; antibodies and antibody fragments, being pharmaceutical preparations for the treatment of cancer, autoimmune diseases, inflammatory conditions, allergies and allergic conditions, hypersensitivity reactions, infections, organ transplant rejection, tissue transplant rejection, cardiovascular diseases, neurological disorders, degenerative disorders, metabolic disorders, dermatological diseases, for use in the manufacture of therapeutic products
Goods and Services
Live animals; live mice
Goods and Services
Treatment and transformation of materials for others, namely the custom manufacture of chemicals, biologicals, antibodies and antibody fragments; contract manufacturing services in the field of chemicals, biologicals, antibodies and antibody fragments; services for the custom manufacture of medical therapies using antibodies and antibody fragments
Goods and Services
Scientific and technological services and research and design relating thereto; medical research laboratory services relating to antibodies and antibody fragments; research into the development of antibodies and antibody fragments; scientific research and development services in relation to antibodies and antibody fragments for medical and veterinary purposes; engineering of antibodies and antibody fragments; scientific services relating to the discovery, preclinical and clinical development of therapeutic products; consultancy services relating thereto
Classification Information
International Class
001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins, unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins, unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes
001, 005, 006, 010, 026, 046
Class Status Code
6 - Active
Class Status Date
2017-06-12
Primary Code
001
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2017-06-12
Primary Code
005
International Class
040 - Treatment of materials. - Treatment of materials.
US Class Codes
100, 103, 106
Class Status Code
6 - Active
Class Status Date
2017-06-12
Primary Code
040
Current Trademark Owners
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
99 - Other (private limited company).
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
99 - Other (private limited company).
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
99 - Other (private limited company).
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
10 - Original Applicant
Legal Entity Type
99 - Other (private limited company).
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Christopher J. Schulte
Address
Please log in with your Justia account to see this address.
International Registrations
International Registration Number
1349229
International Registration Date
2016-10-21
International Publication Date
2017-06-08
International Renewal Date
2026-10-21
Auto Protection Date
2018-12-08
International Status
001 - Request for extension of protection established
International Status Date
2017-06-08
Priority Claimed In
True
Priority Claimed Date
2016-04-22
First Refusal In
True
Trademark Events
| Event Date | Event Description |
| 2017-06-08 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| 2017-06-12 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| 2017-06-12 | ASSIGNED TO EXAMINER |
| 2017-06-14 | NON-FINAL ACTION WRITTEN |
| 2017-06-15 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| 2017-06-16 | APPLICATION FILING RECEIPT MAILED |
| 2017-06-23 | REFUSAL PROCESSED BY MPU |
| 2017-06-23 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| 2017-07-14 | REFUSAL PROCESSED BY IB |
| 2017-12-07 | NEW REPRESENTATIVE AT IB RECEIVED |
| 2017-12-19 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 2017-12-19 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2017-12-20 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2018-01-11 | FINAL REFUSAL WRITTEN |
| 2018-01-12 | FINAL REFUSAL MAILED |
| 2018-02-01 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 2018-02-01 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 2018-02-14 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| 2018-02-14 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2018-02-14 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2018-02-16 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 2018-03-07 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| 2018-03-07 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 2018-03-07 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| 2018-03-24 | NOTIFICATION PROCESSED BY IB |
| 2018-03-27 | PUBLISHED FOR OPPOSITION |
| 2018-03-27 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 2018-06-12 | REGISTERED-PRINCIPAL REGISTER |
| 2018-09-12 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| 2018-09-18 | FINAL DISPOSITION PROCESSED |
| 2018-09-18 | FINAL DISPOSITION NOTICE SENT TO IB |
| 2018-10-06 | FINAL DECISION TRANSACTION PROCESSED BY IB |
